What one share of Assembly Biosciences holds
We are a biotechnology company developing innovative therapeutics targeting serious viral diseases with the potential to improve the lives of patients worldwide.
Assembly Biosciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.00 |
|---|---|
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$2.36 |
| Cash and investments | $1.63 |
| Book value | $15.40 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | — | −$1,480 | $0.00 | −$504.68 | — | — |
| 2011 | — | −$214.34 | $0.07 | −$156.53 | — | $167.01 |
| 2012 | — | −$116.88 | $0.02 | −$100.81 | — | $82.62 |
| 2013 | — | −$60.03 | $0.02 | −$55.08 | — | $70.88 |
| 2014 | — | −$40.79 | $0.26 | −$25.93 | — | $65.86 |
| 2015 | — | −$21.74 | $0.04 | −$14.33 | — | $82.72 |
| 2016 | $0.00 | −$30.83 | $0.10 | −$24.40 | — | $55.58 |
| 2017 | $6.10 | −$28.94 | $0.58 | $0.67 | — | $67.41 |
| 2018 | $7.79 | −$47.76 | $0.18 | −$34.36 | — | $99.15 |
| 2019 | $7.29 | −$44.62 | $0.71 | −$39.13 | — | $100.70 |
| 2020 | $26.79 | −$21.05 | $0.16 | −$21.48 | — | $84.84 |
| 2021 | $1.73 | −$36.00 | $0.86 | −$26.75 | — | $42.13 |
| 2022 | — | −$23.08 | $0.03 | −$20.96 | — | $20.29 |
| 2023 | $1.56 | −$13.38 | $0.06 | $4.91 | — | $7.50 |
| 2024 | $4.75 | −$6.69 | $0.00 | −$8.52 | — | $4.47 |
| 2025 | $6.45 | −$0.55 | $0.01 | −$3.67 | — | $13.04 |
Common questions about Assembly Biosciences
How much does one share of Assembly Biosciences earn?
Over the last 12 months, Assembly Biosciences lost $0.00 for each share.
Does Assembly Biosciences pay a dividend?
Assembly Biosciences didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Assembly Biosciences’s book value per share?
Assembly Biosciences’s book value is $15.40 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Assembly Biosciences have?
Each share of Assembly Biosciences has $1.63 of cash and investments, as of June 30, 2026.
What is Assembly Biosciences’s free cash flow per share?
−$2.36 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Assembly Biosciences bought back shares?
Assembly Biosciences’s share count rose about 108406% from 2010 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.